XML 178 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
REVENUE
 9 Months Ended
Sep. 30, 2022
Revenue from Contract with Customer [Abstract]  
REVENUE REVENUE
Revenues are derived primarily from the sale of dental equipment and dental and healthcare consumable products. Revenues are measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services.

Net sales disaggregated by product category for the three and nine months ended September 30, 2022 and 2021 were as follows:
Three Months EndedNine Months Ended
(in millions)2022202120222021
Equipment & Instruments$163 $176 $498 $523 
CAD/CAM116 147 351 403 
Orthodontics76 63 220 212 
Implants135 150 439 461 
Healthcare66 76 208 225 
Technology & Equipment segment revenue$556 $612 $1,716 $1,824 
Endodontic & Restorative$282 $313 $887 $953 
Other Consumables109 115 336 351 
Consumables segment revenue$391 $428 $1,223 $1,304 
Total net sales$947 $1,040 $2,939 $3,128 

Net sales disaggregated by geographic region for the three and nine months ended September 30, 2022 and 2021 were as follows:
Three Months EndedNine Months Ended
(in millions)2022202120222021
United States$357 $384 $1,023 $1,094 
Europe358 393 1,183 1,239 
Rest of World232 263 733 795 
Total net sales$947 $1,040 $2,939 $3,128 

Contract Assets and Liabilities

The Company normally does not have contract assets in the course of its business. Contract liabilities, which represent billings in excess of revenue recognized, are primarily related to advanced billings for customer aligner treatment where the performance obligation has not yet been fulfilled. The Company had $74 million and $68 million of deferred revenue recorded in Accrued liabilities in the Consolidated Balance Sheets at September 30, 2022 and December 31, 2021, respectively. The Company recognized revenue deferred as of December 31, 2021 of approximately $48 million during the current year. The Company expects to recognize significantly all of the remaining deferred revenue within the next twelve months.

Allowance for Doubtful Accounts

Accounts and notes receivables-trade, net are stated net of allowances for doubtful accounts and trade discounts, which were $9 million at September 30, 2022 and $13 million at December 31, 2021. For the three months and nine months ended September 30, 2022 and 2021, changes to the provision for doubtful accounts including write-offs of accounts receivable that were previously reserved were insignificant. Changes to this provision are included in Selling, general, and administrative expenses in the Consolidated Statements of Operations.